LINC02617

Across TCGA pan-cancer cohorts, LINC02617 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC02617 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher LINC02617 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC02617 expression acts as an unfavorable survival marker, although some lineages such as SKCM and UCEC show a favorable association.

SKCM, UCEC, and HNSC are the cancer types where LINC02617 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	0.849	0.755	.001	94	view →
UCEC	OS	Tertile	All	0.876	0.583	.001	88	view →
HNSC	DFS	Median	All	0.414	0.294	.008	55	view →
BLCA	DFS	Median	II,III,IV	0.449	0.563	.005	39	view →
THCA	DFS	Tertile	II,III,IV	0.735	0.895	.016	36	view →
LGG	DFS	Tertile	All	0.881	0.769	<.001	34	view →
BRCA	OS	Quartile	IV	0.273	0.709	.018	33	view →
SARC	DFS	Quartile	All	0.765	0.581	.007	16	view →
COAD	DFS	Quartile	IV	0.318	0.537	.005	15	view →
KIRP	OS	Median	III,IV	0.622	0.912	.001	14	view →
THYM	DFS	Tertile	II,III,IV	0.524	0.817	.022	12	view →
LUAD	DFS	Quartile	IV	0.333	0.854	.045	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC02617–SKCM (OS)

Open the SKCM breakdown →